Cure Pharmaceutical

United States
California, Oxnard, United States
1(805)824-0410 ★

Company profile

Cure Pharmaceutical company profile

CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety, and patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin films on the market today. CURE is developing an array of products in cutting-edge delivery platforms and partners with biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S.,..... For more information, log in to dureach.com to view the full company profile.

Business identity

Contact email
[email protected]
Phone number
1(805)824-0410
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2011-07-01

Headquarters

Headquarters
California, Oxnard, United States
Postal code
93033
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
3
Total equity funding
$19M
Last funding
Debt Financing / $625K / 2022-09-14
Last equity funding
Post Ipo Equity / $19M
Founders
1
Articles
20
Exited on
2017-01-18

Founders and investors

Founders

Robert Davidson

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.